Sorafenib improves lipiodol deposition in transarterial chemoembolization of Chinese patients with hepatocellular carcinoma: a long-term, retrospective study

OBJECTIVE: Though synergy of sorafenib and transarterial chemoembolization (TACE) in hepatocellular carcinoma (HCC) is well discussed in previous reports, association of lipiodol retention by sorafenib addition to TACE with the survival outcomes remain elusive. Therefore, we studied the impact of so...

Descripción completa

Detalles Bibliográficos
Autores principales: Zheng, Lin, Guo, Chen-Yang, Chen, Cheng-Shi, Xiao, Jin-Cheng, Hu, Hong-Tao, Cheng, Hong-Tao, Zong, Deng-Wei, Jiang, Li, Li, Hai-Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Impact Journals LLC 2017
Materias:
Clinical Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722589/
https://www.ncbi.nlm.nih.gov/pubmed/29228637
http://dx.doi.org/10.18632/oncotarget.18811

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5722589/
https://www.ncbi.nlm.nih.gov/pubmed/29228637
http://dx.doi.org/10.18632/oncotarget.18811

Ejemplares similares